AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Infectious Disease Diagnostics
... projected to reach a revised size of US$20.8 Billion by 2027, growing at a CAGR of 4% over the analysis period 2020-2027. Assays, Kits, & Reagents, one of the segments analyzed in the report, is ... Read More
-
Gonorrhea Global Clinical Trials Review, H2, 2020
... to the clinical trials on Gonorrhea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ... Read More
-
Global Gonorrhea Therapeutics Market 2020-2024
... period. Our reports on gonorrhea therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Artificial Intelligence (AI) in HIV/AIDS
... image processing, and speech recognition -- and their practical healthcare applications which include diagnosis, therapy, R&D, and health management in the field of HIV/AIDS - Data corresponding to global AI markets and their employability in ... Read More
-
Anal Fissure Global Clinical Trials Review, H2, 2020
... line data relating to the clinical trials on Anal Fissure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
-
Molecular Diagnostics Markets in The COVID-19 Era
... the growth of the worldwide market for molecular diagnostics in all major segments, and does so in this edition as a pandemic has reached developed markets including the United States. 2020 was set to be ... Read More
-
Global Herpes Treatment Market 2020-2024
... period. Our reports on herpes treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
... for the duration spanning 2020-2024. The factors such as increasing prevalence of HIV, rising incidences of cancer cases, increasing medical technology R&D spending, growth in geriatric population, upsurge in healthcare expenditures, rise of multiplex immunoassays ... Read More
-
Global Anti-Viral Drugs Market Analysis 2020 - Forecast to 2027
... derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next eight years, including a deep dive analysis of market segmentation which ... Read More
-
Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis), by Type (Full line Wholesalers and Specialty Distributors), by Distribution Type, by Distribution Channel - United
... to 2025 - Cumulative Impact of COVID-19 The United States Specialty Drug Distribution Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional ... Read More
-
Antiviral Drugs Market Research Report by Drug Type (Branded Drugs and Generic Drugs), by Therapeutics (HIV/Aids Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics, Influenza Therapeutics, and Pneumonia), by End Use - United States Forecast
... Forecast to 2025 - Cumulative Impact of COVID-19 The United States Antiviral Drugs Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional ... Read More
-
Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027
... market is expected to grow at a CAGR of 7.4% from 2020 to 2027 to reach $23.17 billion by 2027. Succeeding an extensive secondary and primary research and in-depth analysis of the market scenario, the ... Read More
-
HIV/AIDS Testing
... a revised size of US$5.6 Billion by 2027, growing at a CAGR of 7.9% over the analysis period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record a 7.9% CAGR ... Read More
-
Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s -Pipeline Insight, 2020
... Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s pipeline landscape is provided, which includes the topic overview and Nucleotide Analog Reverse Transcriptase Inhibitor (NtRTI)s mechanism of action. The assessment part of the report embraces, in-depth Nucleotide Analog ... Read More
-
Neisseria gonorrhoeae Infections Global Clinical Trials Review, H1, 2020
... report provides top line data relating to the clinical trials on Neisseria gonorrhoeae Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers ... Read More
-
Companion Diagnostic Markets - The Future Of Diagnostics
... immune-oncology is leading the way. And the FDA is holding the door open for this diagnostic technology of the future. But COVID-19 is impacting healthcare treatment everywhere and lowering demand for specialized cancer testing. Find ... Read More
-
Pandemic Outbreaks in the Past Decade: A BCC Research Overview
... impact, R&D efforts, treatment and diagnostics, clinical trial landscape, and regulatory and reimbursement landscape - Data corresponding to number of confirmed cases and reported deaths (globally and country wise) due to various pandemics, including novel ... Read More
-
SYNDROMIC MULTIPLEX DIAGNOSTIC MARKETS with COVID-19 Impact. Strategies and Trends
... Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster? Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics. Are targeted ... Read More
-
Syphilis Immunoassay Diagnostic Market Research Report by Product (Analyzer and Kit & Reagent), by Technology (CLIA and ELISA), by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19
... Immunoassay Diagnostic Market to grow USD 395.89 Million by 2025, at a CAGR of 7.47%. The Global Syphilis Immunoassay Diagnostic Market is expected to grow from USD 256.87 Million in 2019 to USD 395.89 Million ... Read More
-
Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country
... takes center stage. The Molecular Diagnostics – Infectious Disease sector of the clinical diagnostics industry is poised for record growth. A market that just keeps on growing but is spiking as an enormous C19Dx demand ... Read More
-
Antiviral Drugs Market Research Report by Drug Type (Branded Drugs and Generic Drugs), by Therapeutics (HIV/Aids Therapeutics, Hepatitis (B & C) Therapeutics, Herpes Therapeutics, Influenza Therapeutics, and Pneumonia), by End Use - Global Forecast to 202
... to 2025 - Cumulative Impact of COVID-19 The Global Antiviral Drugs Market to grow USD 61,347.42 Million by 2025, at a CAGR of 5.50%. The Global Antiviral Drugs Market is expected to grow from USD ... Read More
-
Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2020
... (Infectious Disease) pipeline landscape. Oral herpes is an infection of the lips, mouth, or gums due to the herpes simplex virus. Oral herpes is also called herpes labialis. Symptoms include sore throat, fever, swollen glands ... Read More
-
Glycoprotein 41 - Pipeline Review, H1 2020
... cells. It is a subunit of the envelope protein complex of retroviruses. The interaction of gp41 fusion peptides with the target cell causes a formation of an intermediate structure which bridges and fuses the viral ... Read More
-
Emerging Infectious Disease Diagnostics: Markets and Trends
... of preparation for a viral epidemic. He predicted that it would be “microbes, not missiles” that would cause significant harm to humans. Events in recent years have proven him right. Outbreaks of infections such as ... Read More
-
Global Infectious Diseases Diagnostics Market (By Products, End-Users & Regions): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
... of 3.30% for the duration spanning 2020-2024. The factors such as increasing prevalence of HIV infection, expansion of medical devices market, growth in geriatric population, increasing medical technology R&D spending, rapid urbanization and upswing in ... Read More
